FORTIS — Fortis Healthcare Share Price
- IN₹509.75bn
- IN₹524.11bn
- IN₹68.93bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 51.47 | ||
PEG Ratio (f) | 3.65 | ||
EPS Growth (f) | 16.41% | ||
Dividend Yield (f) | 0.21% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 6.3 | ||
Price to Tang. Book | 15.19 | ||
Price to Free Cashflow | 138.02 | ||
Price to Sales | 6.54 | ||
EV to EBITDA | 33.89 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 11.02% | ||
Return on Equity | 9.95% | ||
Operating Margin | 14.88% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 46,323.2 | 40,301.2 | 57,176.12 | 62,976.32 | 68,929.17 | 77,952.01 | 88,458.94 | 9.05% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | +72.65 | +12.66 | +41.15 | +16.41 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Fortis Healthcare Limited is an India-based integrated healthcare service provider. The Company is primarily engaged in the business of healthcare services. Its segment includes the Healthcare business and the Diagnostics business. The healthcare business includes inpatient and outpatient services, sale of medical and nonmedical items and management fees from hospitals. The diagnostic business includes pathology and radiology services. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant, among others. The healthcare verticals of the Company primarily consist of day care specialty, diagnostics and tertiary and quaternary care. The Company has approximately 28 healthcare facilities, including projects under development, 4500 operational beds and over 400 diagnostics centers. It operates in India, the United Arab Emirates, Nepal, and Sri Lanka.
Directors
- Ashutosh Raghuvanshi CEO
- Vivek Goyal CFO
- Sumit Goel SEC
- Soon Teck Low DRC (56)
- See Leng Tan DRC (54)
- Joerg Ayrle NED
- Farid bin Mohamed Sani NED (45)
- Sunil Godhwani NED
- Sim Heng Joo Joe NED
- Chi-Keon Loh NED (47)
- Takeshi Saito NED (49)
- Indrajit Banerjee IND (62)
- Suvalaxmi Chakraborty IND (53)
- Shailaja Chandra IND
- Gurcharan Das NID (71)
- Joji Gill NID
- Shradha Marwah NID
- Ravi Rajagopal NID (65)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 28th, 1996
- Public Since
- May 9th, 2007
- No. of Shareholders
- 163,630
- No. of Employees
- 2,593
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
National Stock Exchange of India
- Shares in Issue
- 754,958,148

- Address
- Tower A, Block - F, GURGAON, 122001
- Web
- https://www.fortishealthcare.com/
- Phone
- +91 1244921021
- Contact
- Satyendra Chauhan
- Auditors
- BSR & Co. LLP
Upcoming Events for FORTIS
Q1 2026 Fortis Healthcare Ltd Earnings Release
Similar to FORTIS
Aatmaj Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
Aster DM Healthcare
National Stock Exchange of India
Chandan Healthcare
National Stock Exchange of India
FAQ
As of Today at 20:40 UTC, shares in Fortis Healthcare are trading at IN₹654.65. This share price information is delayed by 15 minutes.
Shares in Fortis Healthcare last closed at IN₹654.65 and the price had moved by +47.16% over the past 365 days. In terms of relative price strength the Fortis Healthcare share price has outperformed the S&P BSE 100 Index by +38.63% over the past year.
The overall consensus recommendation for Fortis Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Fortis Healthcare dividend yield is 0.15% based on the trailing twelve month period.
Last year, Fortis Healthcare paid a total dividend of IN₹1.00, and it currently has a trailing dividend yield of 0.15%. We do not have any data on when Fortis Healthcare is to next pay dividends.
We do not have data on when Fortis Healthcare is to next pay dividends. The historic dividend yield on Fortis Healthcare shares is currently 0.15%.
To buy shares in Fortis Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹654.65, shares in Fortis Healthcare had a market capitalisation of IN₹509.75bn.
Here are the trading details for Fortis Healthcare:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: FORTIS
Based on an overall assessment of its quality, value and momentum Fortis Healthcare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Fortis Healthcare is IN₹707.11. That is 8.01% above the last closing price of IN₹654.65.
Analysts covering Fortis Healthcare currently have a consensus Earnings Per Share (EPS) forecast of IN₹10.93 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fortis Healthcare. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +14.71%.
As of the last closing price of IN₹654.65, shares in Fortis Healthcare were trading +7.02% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Fortis Healthcare PE ratio based on its reported earnings over the past 12 months is 51.47. The shares last closed at IN₹654.65.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Fortis Healthcare's management team is headed by:
- Ashutosh Raghuvanshi - CEO
- Vivek Goyal - CFO
- Sumit Goel - SEC
- Soon Teck Low - DRC
- See Leng Tan - DRC
- Joerg Ayrle - NED
- Farid bin Mohamed Sani - NED
- Sunil Godhwani - NED
- Sim Heng Joo Joe - NED
- Chi-Keon Loh - NED
- Takeshi Saito - NED
- Indrajit Banerjee - IND
- Suvalaxmi Chakraborty - IND
- Shailaja Chandra - IND
- Gurcharan Das - NID
- Joji Gill - NID
- Shradha Marwah - NID
- Ravi Rajagopal - NID